BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 29770626)

  • 1. Practice guidelines for management of ovarian cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement.
    Suh DH; Chang SJ; Song T; Lee S; Kang WD; Lee SJ; Roh JW; Joo WD; Yoon JH; Jeong DH; Kim HS; Lee SJ; Ji YI; Kim HJ; Lee JW; Kim JW; Bae DS
    J Gynecol Oncol; 2018 Jul; 29(4):e56. PubMed ID: 29770626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement.
    Lim MC; Lee M; Shim SH; Nam EJ; Lee JY; Kim HJ; Lee YY; Lee KB; Park JY; Kim YH; Ki KD; Song YJ; Chung HH; Kim S; Lee JW; Kim JW; Bae DS; Lee JM
    J Gynecol Oncol; 2017 May; 28(3):e22. PubMed ID: 28382794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement.
    Lee SW; Lee TS; Hong DG; No JH; Park DC; Bae JM; Seong SJ; Shin SJ; Ju W; Lee KH; Lee YK; Cho H; Lee C; Paek J; Kim HJ; Lee JW; Kim JW; Bae DS
    J Gynecol Oncol; 2017 Jan; 28(1):e12. PubMed ID: 27894165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines.
    Lee B; Chang SJ; Kwon BS; Son JH; Lim MC; Kim YH; Lee SW; Choi CH; Eoh KJ; Lee JY; Suh DH; Kim YB
    J Gynecol Oncol; 2024 Jan; 35(1):e43. PubMed ID: 38178704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SEOM clinical guideline in ovarian cancer (2020).
    Redondo A; Guerra E; Manso L; Martin-Lorente C; Martinez-Garcia J; Perez-Fidalgo JA; Varela MQ; Rubio MJ; Barretina-Ginesta MP; Gonzalez-Martin A
    Clin Transl Oncol; 2021 May; 23(5):961-968. PubMed ID: 33515422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer.
    Komiyama S; Katabuchi H; Mikami M; Nagase S; Okamoto A; Ito K; Morishige K; Suzuki N; Kaneuchi M; Yaegashi N; Udagawa Y; Yoshikawa H
    Int J Clin Oncol; 2016 Jun; 21(3):435-46. PubMed ID: 27142770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer.
    Tokunaga H; Mikami M; Nagase S; Kobayashi Y; Tabata T; Kaneuchi M; Satoh T; Hirashima Y; Matsumura N; Yokoyama Y; Kawana K; Kyo S; Aoki D; Katabuchi H
    J Gynecol Oncol; 2021 Mar; 32(2):e49. PubMed ID: 33650343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Follow-up of patients treated for an epithelial ovarian cancer, place of hormone replacement therapy and of contraception: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
    Sénéchal C; Akladios C; Bendifallah S; Ouldamer L; Lecuru F; Rousset-Jablonski C
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):250-262. PubMed ID: 30685388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms.
    Chicago Consensus Working Group
    Cancer; 2020 Jun; 126(11):2553-2560. PubMed ID: 32282068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial ovarian cancer: Evolution of management in the era of precision medicine.
    Lheureux S; Braunstein M; Oza AM
    CA Cancer J Clin; 2019 Jul; 69(4):280-304. PubMed ID: 31099893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NIH consensus conference. Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer.
    JAMA; 1995 Feb; 273(6):491-7. PubMed ID: 7837369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†.
    Colombo N; Sessa C; du Bois A; Ledermann J; McCluggage WG; McNeish I; Morice P; Pignata S; Ray-Coquard I; Vergote I; Baert T; Belaroussi I; Dashora A; Olbrecht S; Planchamp F; Querleu D;
    Ann Oncol; 2019 May; 30(5):672-705. PubMed ID: 31046081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference.
    Stuart GC; Kitchener H; Bacon M; duBois A; Friedlander M; Ledermann J; Marth C; Thigpen T; Trimble E; ;
    Int J Gynecol Cancer; 2011 May; 21(4):750-5. PubMed ID: 21543936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of epithelial ovarian cancer.
    Leitao MM
    Clin Adv Hematol Oncol; 2018 Oct; 16(10):656-659. PubMed ID: 30543594
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of systemic therapy in women with recurrent ovarian cancer--development of a national clinical practice guideline.
    Elit L; Zitzelsberger L; Fung-Kee-Fung M; Brouwers M; Graham ID; Browman G; Hoskins P; Lau S; Ghatage P;
    Gynecol Oncol; 2007 Jul; 106(1):181-92. PubMed ID: 17498781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practice guidelines: uterine corpus--endometrial cancer. Society of Gynecologic Oncologists Medical Practice Committee.
    Oncology (Williston Park); 1998 Jan; 12(1):122-6. PubMed ID: 9474591
    [No Abstract]   [Full Text] [Related]  

  • 17. Opportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention: a survey of Gynecologic Oncology Committee of Japan Society of Obstetrics and Gynecology.
    Mikami M; Nagase S; Yamagami W; Ushijma K; Tashiro H; Katabuchi H;
    J Gynecol Oncol; 2017 Jul; 28(4):e52. PubMed ID: 28541639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Japan Society of Gynecologic Oncology guidelines 2011 for the treatment of uterine cervical cancer.
    Ebina Y; Yaegashi N; Katabuchi H; Nagase S; Udagawa Y; Hachisuga T; Saito T; Mikami M; Aoki Y; Yoshikawa H
    Int J Clin Oncol; 2015 Apr; 20(2):240-8. PubMed ID: 25800808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors).
    Harter P; Gershenson D; Lhomme C; Lecuru F; Ledermann J; Provencher DM; Mezzanzanica D; Quinn M; Maenpaa J; Kim JW; Mahner S; Hilpert F; Baumann K; Pfisterer J; du Bois A
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S5-8. PubMed ID: 25341581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated Urethral Metastasis From a Primary Ovarian Malignancy.
    Allan M; Tailor A; Butler-Manuel S; Madhuri TK
    J Obstet Gynaecol Can; 2018 Dec; 40(12):1632-1634. PubMed ID: 30262385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.